NatureWise Biotech & Medicals Profit Margin

NatureWise Biotech & Medicals's profit margin stands at -48.86% as of June 2026. That compares with 7.3% in the prior-year period — down 769.0% year over year. That is below the Healthcare sector average of 9.71%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

NatureWise Biotech & Medicals reported -48.86% in profit margin versus 7.3% a year earlier — a 769.0% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

NatureWise Biotech & Medicals sits lower the Healthcare benchmark (9.71%) with a profit margin of -48.86%. That is roughly 603.4% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -48.86% for NatureWise Biotech & Medicals means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how NatureWise Biotech & Medicals's profit margin evolved across reporting periods, while the comparison chart places 4732.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.